Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex
Authors
Keywords
-
Journal
Open Biology
Volume 4, Issue 6, Pages 140030-140030
Publisher
The Royal Society
Online
2014-06-12
DOI
10.1098/rsob.140030
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth
- (2013) Yael Nemlich et al. JOURNAL OF CLINICAL INVESTIGATION
- Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma
- (2013) Ming-Qi Fan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma
- (2013) Cheng-Chi Chang et al. ORAL ONCOLOGY
- Alteration in Metastasis Potential and Gene Expression in Human Lung Cancer Cell Lines by ITGB8 Silencing
- (2012) Zhaoguo Xu et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells
- (2012) Hong-Wei Kang et al. FEBS LETTERS
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation
- (2011) S. Jiang et al. BLOOD
- miR-20a Encoded by the miR-17-92 Cluster Increases the Metastatic Potential of Osteosarcoma Cells by Regulating Fas Expression
- (2011) G. Huang et al. CANCER RESEARCH
- Glioblastoma Angiogenesis and Tumor Cell Invasiveness Are Differentially Regulated by 8 Integrin
- (2011) J. H. Tchaicha et al. CANCER RESEARCH
- Gene silencing by microRNAs: contributions of translational repression and mRNA decay
- (2011) Eric Huntzinger et al. NATURE REVIEWS GENETICS
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs
- (2011) Eyal Greenberg et al. PLoS One
- miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells
- (2010) X. Fan et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia
- (2010) Ulf Klein et al. CANCER CELL
- miR-31 Ablates Expression of the HIF Regulatory Factor FIH to Activate the HIF Pathway in Head and Neck Carcinoma
- (2010) C.-J. Liu et al. CANCER RESEARCH
- Concurrent Suppression of Integrin α5, Radixin, and RhoA Phenocopies the Effects of miR-31 on Metastasis
- (2010) Scott Valastyan et al. CANCER RESEARCH
- The miR-17-92 Cluster of MicroRNAs Confers Tumorigenicity by Inhibiting Oncogene-Induced Senescence
- (2010) L. Hong et al. CANCER RESEARCH
- Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers
- (2010) C. J. Creighton et al. CANCER RESEARCH
- Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma
- (2010) Sergey V. Ivanov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8
- (2010) L Fang et al. ONCOGENE
- microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling
- (2010) Z. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNAs in Cancer
- (2009) Ramiro Garzon et al. Annual Review of Medicine
- RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
- (2009) Scott Valastyan et al. CELL
- Genetic dissection of the miR-17 92 cluster of microRNAs in Myc-induced B-cell lymphomas
- (2009) P. Mu et al. GENES & DEVELOPMENT
- Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance
- (2009) Yuanyuan Zhang et al. MEDICAL ONCOLOGY
- Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2
- (2008) Kelly J. Gordon et al. CARCINOGENESIS
- Pre-miRNA Loop Nucleotides Control the Distinct Activities of mir-181a-1 and mir-181c in Early T Cell Development
- (2008) Gwen Liu et al. PLoS One
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now